| Name | Olutasidenib |
|---|
| Description | Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia. |
|---|---|
| Related Catalog | |
| Target |
IDH1[1]. |
| References |
| Molecular Formula | C18H15ClN4O2 |
|---|---|
| Molecular Weight | 354.79 |